Pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and in continuation of our intimation dated May 21, 2026 regarding the schedule ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Asarfi Hospital Limited disclosed that it participated in a one-to-one investor meeting on May 27, 2026, organized by Chorus Call Conferencing Services through a virtual platform. The meeting was attended by Managing Director Mr. Udai Pratap Singh, CFO Mr. Harendra Singh, and Chief Manager – Finance Mr. Suraj Hazari. The company clarified that only publicly available information was shared during the meeting and confirmed that no Unpublished Price Sensitive Information (UPSI) was communicated to the Institutional Investors or Analysts. This filing follows an earlier intimation dated May 21, 2026 regarding the scheduled meeting.
This is a routine compliance disclosure confirming the conduct of an investor meeting with no new material information or price-sensitive details revealed. It has no direct impact on the stock price or shareholder value in the near term.